Services and laboratories » "Giorgio Spagnol" Neuroimmunology Clinic, for the Diagnosis and Treatment of Disimmune Neuropathies » Publications

Main articles published in the last 5 years (1998-2003)

Spagnol G, Doneda P, Cavanna B, Sgarzi M, Manfredini E, Allaria S, Scarlato G, Nobile-Orazio E. Expression of glycosylated recombinant human myelin-associated glycoprotein (MAG) on a neuroblastoma cell line and its reactivity with HNK-1 but not human anti-MAG antibodies. Neurosci Lett 1998; 246(3): 157-160.61.

Meucci N, Baldini L, Cappelari A, Di Troia A, Allaria S, Scarlato G, Nobile-Orazio E. Anti-MAG antibodies predict the development of neuropathy in asymptomatic patients with IgM monoclonal gammopathy. Ann Neurol 1999; 46: 119-122.

Nobile-Orazio E, Meucci N, Baldini L, Di Troia A, Scarlato G. Long-term prognosis of neuropathy associated with anti-MAG IgM M-proteins and its relation with immune therapies. Brain 2000; 123: 710-717.

Nobile-Orazio E, Carpo M. Neuropathy and monoclonal gammopathy. Curr Opin Neurology 2001; 14: 615-620.

Lunn M., Nobile-Orazio E. Immunnotherapy for IgM anti-Myelin-associated Gglycoprotein paraprotein associated neuropathy. The Cochrane Library 2003; Issue 1. Oxford :Update Software

Comi G, Roveri L, Swan A, Willison H, Bojar M, Illa I, Karageorgiou C, Nobile-Orazio E, van den Bergh P, Swan T, Hughes RAC and the Inflammatory Neuropathy Cause and Treatment (INCAT) group. A randomised controlled trial of intravenous immunoglobulin in IgM paraprotein associated demyelinating neuropathy. J Neurol 2002; 249: 1370-1377

Carpo M, Meucci N, Allaria S, Marmiroli P, Monaco S, Toscano A, Simonetti S, Scarlato G, Nobile-Orazio E. Anti-sulfatide IgM antibodies in peripheral neuropathy.J Neurol Sci 2000; 176: 144-150.

Ferrari S, Morbin M, Nobile-Orazio E, Musso A, Tomelleri G, Bertolasi L, Rizzuto N, Monaco S. Anti-sulfatide neuropathy: antibody mediated complement attack to peripheral myelin. Acta Neuropathologica 1998; 96: 569-574.

Carpo M, Pedotti R, Lolli F, et al . Clinical correlate and fine specificity of anti-GQ1b antibodies in peripheral neuropathy. J Neurol Sci 1998; 155: 186-191.

Cavanna B, Carpo M, Pedotti R, et al. Anti-GM2 IgM antibodies: clinical correlates and reactivity with a human neuroblastoma cell line. J Neuroimmunol 1999; 94: 157-164).

Cavanna B, Jiang H, Allaria S, Carpo M, Scarlato G, Nobile-Orazio E. Anti-GM2 IgM antibody-induced complement-mediated cytotoxicity in patients with dysimmune neuropathies. J Neuroimmunol 2001; 114: 226-231.

Di Troia A, Carpo M, Meucci N, Pellegrino C, Allaria S, Gemignani F, Marbini A, Mantegazza R, Sciolla R, Manfredini E, Scarlato G, Nobile-Orazio E. Clinical features and anti-neural reactivity in neuropathy associated with IgG monoclonal gammopathy of undetermined significance. J Neurol Sci 1999; 164: 64-71

Nobile-Orazio E, Casellato C, Di Troia A. Neuropathies associated with IgG and IgA monoclonal gammopathy. Revue Neurologique (Paris) 2002; 158: 979-987

Nobile-Orazio E. Multifocal motor neuropathy. (Review Article). J Neuroimmunol 2001; 115: 4-18

European workshop on multifocal neuropathy. Hughes RAC, and other partecipants (including Eduardo Nobile-Orazio). 79th ENMC interantional workshop: Multifocal motor neuropathy (Workshop report). Neuromusc dis 2001; 11: 309-314.

Carpo M, Allaria S, Scarlato G, Nobile-Orazio E. Marginally improved detection of GM1 antibodies by covalink ELISA in multifocal motor neuropathy. Neurology 1999; 53: 2206-7.

Carpo M, Cappellari A, Mora G, et al. Deterioration of multifocal motor neuropathy after plasma exchange. Neurology 1998; 50:1480-1482.

Nobile-Orazio E, Meucci N. High-dose intravenous immuno-globulins in multifocal motor neuropathy. EEG Clinical Neurophysiol 1999; (Suppl. 50): 506-513.

Nobile-Orazio E, Meucci N, Carpo M, Terenghi, Bersano A, Cappellari A, Barbieri S, Scarlato G. Multifocal motor neuropathy: clinical and immunological features and response to IVIg in relation to the presence and degree of motor conduction block. J Neurol Neurosurg Psychiatry 2002; 72: 761-766.

Terenghi F, Cappellari A, Carpo M, Bersano A, Barbieri, Nobile-Orazio E. How long is IVIg effective in multifocala motor neuropathy?. Neurology in press

Priori A, Cinnante C, Pesenti A, Carpo M, Cappellari A, Nobile-Orazio E, Scarlato G, Barbieri S Distinctive abnormalities of motor axonal strength-duration properties in multifocal motor neuropathy and in motor neuron disease Brain 2002;125: 2481-90

Terenghi F, Allaria S, Scarlato G, Nobile-Orazio E. Multifocal motor neuropathy and Campylobacter jejuni reactivity. Neurology 2002; 59:282-284

Nobile-Orazio E, Carpo M, Meucci N. Are there immunologically treatable motor neuron diseases? Amyotrophic lateral sclerosis and other motor neuron disorders 2001; 2 (suppl 1): S23-S30.

Guillain-Barré Syndrome Study group. The Guillain-Barré syndrome: an Italian multicenter case-control study. Neurological Sciences 2000; 21: 229-234

Maccario M, Tarantino A, Nobile-Orazio E, Ponticelli C. Campylobacter jejuni bacteremia and Guillain Barré syndrome in a renal transplant recipient. Transplant International 1998; 11: 439-442.

Carpo M, Pedotti R, Allaria S et al. Clinical presentation and outcome of Guillain-Barré and related syndromes in relation to anti-ganglioside antibodies. J Neurol Sci 1999, 168: 78-84.

Odaka M, Yuki N, Nobile-Orazio E, Carpo M, Hiraka K. Antibodies to GM1(NeuGc) in Guillain Barré syndrome after ganglioside therapy. J Neurol Sci 2000; 175: 96-106.

Pedotti R, Carpo M, Lucchi S, et al. Lumbosacral root and facial nerve enhancement in Miller Fisher syndrome. J Neurol 1998; 245: 753-754.

Carpo M, Pedotti R, Lolli F. Pitrola A. Allaria S, Scarlato G, Nobile-Orazio E. Clinical correlate and fine specificity of anti-GQ1b antibodies in peripheral neuropathy. J Neurol Sci 1998; 155: 186-191

Buchwald B, Bufler J, Carpo M, Heidenreich F, Pitz R, Dudel J, Nobile-Orazio E, Toyka KV. Combined pre- and postsynaptic action of IgG antibodies in Miller Fisher syndrome. Neurology 2001; 56: 67-74.

Hughes RAC, Bensa S, Willison HJ, van den Bergh P, Comi G, Illa I, Nobile-Orazio E, van Doorn P, Dalakas M, Bojar M, Swan A and the Inflammatory Neuropathy Cause and Treatment (IINCAT) group. Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 2001; 50: 195-201.

Nobile-Orazio E, Carpo M, Allaria S, Gamba M. Diagnostic relevance of anti-neural antibodies in dysimmune neuropathies EEG Clinical Neurophysiol 1999; (Suppl. 50): 419-427.

Nobile-Orazio E, Carpo M. Rilevanza diagnostica degli anticorpi antinervo nelle neuropatie disimmuni. Italian Journal of Neurological Sciences 1998; 19 (suppl): S136-S140.

Nobile-Orazio E, Carpo M. Terapia con immunoglobuline nelle terapie disimmuni. Neurological Sciences 2000; 21 (Supplement): S681-688.